Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
7,754,027
Share change
+2,055,806
Total reported value
$30,238,589
Price per share
$3.90
Number of holders
47
Value change
+$7,294,468
Number of buys
25
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2017

As of 31 Mar 2017, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,754,027 shares. The largest 10 holders included FMR LLC, JPMORGAN CHASE & CO, ROYCE & ASSOCIATES LP, BlackRock Inc., STIFEL FINANCIAL CORP, SPHERA FUNDS MANAGEMENT LTD., NEXTHERA CAPITAL LP, VANGUARD GROUP INC, Opus Point Partners Management, LLC, and Sio Capital Management, LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.